KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,781 | +17.7% | 7,011 | -4.6% | 0.00% | – |
| Q2 2023 | $103,502 | +25.4% | 7,351 | -4.2% | 0.00% | – |
| Q1 2023 | $82,561 | -7.8% | 7,673 | +28.3% | 0.00% | – |
| Q4 2022 | $89,565 | -18.6% | 5,979 | -30.1% | 0.00% | -100.0% |
| Q3 2022 | $110,000 | +32.5% | 8,549 | 0.0% | 0.00% | – |
| Q2 2022 | $83,000 | +16.9% | 8,549 | +19.3% | 0.00% | – |
| Q1 2022 | $71,000 | -15.5% | 7,164 | 0.0% | 0.00% | – |
| Q4 2021 | $84,000 | +300.0% | 7,164 | +290.0% | 0.00% | – |
| Q3 2021 | $21,000 | -19.2% | 1,837 | 0.0% | 0.00% | – |
| Q2 2021 | $26,000 | -23.5% | 1,837 | 0.0% | 0.00% | – |
| Q1 2021 | $34,000 | +6.2% | 1,837 | 0.0% | 0.00% | – |
| Q4 2020 | $32,000 | +14.3% | 1,837 | 0.0% | 0.00% | – |
| Q3 2020 | $28,000 | – | 1,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |